Put operating results in leadership context

Review returns on capital, executive background, insider transactions, and growth quality to judge whether management is compounding value well.

Management quality matters because capital allocation choices determine how much of Brookfield Corporation earnings power becomes long-term shareholder value. Use this page to compare BN returns on capital, executive context, insider transactions, ownership signals, and growth trends against peers, then decide whether leadership appears disciplined, aligned, and capable of compounding through changing market conditions.

Return Metrics

ROE, ROIC & ROA over time

Management

Older years hidden. Sign in to unlock

ROE

2.7%

avg 5.5%

ROIC

3.2%

avg 2.7%

ROA

0.3%

avg 0.7%

Analysis

ROIC is currently the strongest return metric at 3.2% versus its period average of 2.7%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.

Management

Key executives, compensation & ownership

Management

Name	Title	Compensation	Tenure	Age	Shares Owned	Ownership %
Connor David Teskey	CEO of Brookfield Asset Management & CEO Energy	$2.36M	—	39	$0.00	<0.01%
Nicholas H. Goodman	President & Chief Financial Officer	$1.83M	—	44	—	—
Brian William Kingston	Executive Chair of Real Estate	$1.50M	—	53	—	—
Cyrus Madon	Executive Chair of Private Equity	$390,082.00	—	60	—	—
James Bruce Flatt	CEO & Management and Affiliated Director	$375,000.00	—	61	—	—
Pierre McNeil	Managing Director of Private Equity	—	—	63	—	—
Qi Yang	Managing Partner & Head of East Asia	—	—	—	—	—
Tristan John Tully	Managing Partner of Private Equity & Head of U.S Private Equity	—	—	39	$0.00	<0.01%
Sophia Rihani	Managing Director of Private Equity & Head of Transaction Execution for Asia Pacific & Middle East	—	—	—	—	—
David James Nowak	President of Private Equity	—	—	56	$0.00	<0.01%
Fernando Garcia Rossel	General Manager	—	—	—	—	—
Gregory N. McConnie	Chief Executive Officer, Director of NER SPC and CEO of NER Ltd & MD of Brookfield Reinsurance	—	—	53	—	—
John Michael Sweeney	Chief Executive Officer of Brookfield Oaktree Health Solutions	—	—	—	$0.00	<0.01%
Anuj Ranjan	Chief Executive Officer of Private Equity	—	—	47	—	—
Ryan Szainwald	Managing Partner of Private Equity	—	—	—	—	—
Adrian Letts	Managing Partner of Private Equity & Head of Business Operations	—	—	—	—	—
Dave Gregory	Managing Partner & Chief Investment Officer of Private Equity	—	—	—	—	—
Denis Andre Turcotte	Managing Partner of Private Equity	—	—	65	—	—
Erson Olivan	Managing Partner of Private Equity & Co-Head of Special Investments strategy	—	—	—	—	—

Insider Trading

SEC Form 4 transactions — last 12 months

Management

No insider transactions in the last 12 months.

Growth Analysis

Historical CAGR & forward analyst estimates

Growth

Metric	10yr	5yr	3yr	Fwd Est.
EPS	N/A	N/A	+19.7%	+11.4% (13yr)1 analysts
Revenue	N/A	N/A	+2.0%	-4.5% (13yr)1 analysts
Net Income	N/A	N/A	+19.3%	+11.6% (13yr)1 analysts
EBIT	N/A	N/A	+2.8%	-2.4% (13yr)1 analysts

Analysis

Recent growth has been strongest in EPS at +19.7% over three years. Forward estimates point to Net Income at +11.6% (13yr), giving you a quick check on whether expectations are accelerating or cooling.